All data are based on the daily closing price as of November 20, 2026
c

Chong Kun Dang Pharmaceutical

185750.KO
46.47 USD
-0.16
-0.34%

Overview

Last close
46.47 usd
Market cap
612.29M usd
52 week high
69.35 usd
52 week low
41.76 usd
Target price
76.41 usd

Valuation

P/E
10.2789
Forward P/E
N/A
Price/Sales
0.459
Price/Book Value
0.7939
Enterprise Value
687.24M usd
EV/Revenue
0.5176
EV/EBITDA
2.1534

Key financials

Revenue TTM
1.32B usd
Gross Profit TTM
394.53M usd
EBITDA TTM
91.34M usd
Earnings per Share
4.48 usd
Dividend
0.37 usd
Total assets
1.38B usd
Net debt
N/A usd

About

Chong Kun Dang Pharmaceutical Corp. manufactures, markets, and sells medicines in South Korea and internationally. It offers prescription drugs for anti-hypertension, anti-hyperlipidaemia, and anti-diabetics, as well as immunosuppressants; over-the-counter medicines; and consumer health products, such as insecticides and hair dye products, as well as health supplements. The company was founded in 1941 and is headquartered in Seoul, South Korea.
  • Symbol
    185750.KO
  • Exchange
    KO
  • Isin
    KR7185750007
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Young-Joo Kim
  • Headquarter
    Seoul
  • Web site
    https://www.ckdpharm.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top